Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
OVCH1 antisense RNA 1 (OVCH1-AS1) is a long non-coding RNA (lncRNA) transcribed from the antisense strand of the OVCH1 locus on human chromosome 12[1][3][4][6][8]. It belongs to the class of antisense lncRNAs, which are known to modulate gene expression via epigenetic and transcriptomic mechanisms, such as chromatin remodeling, transcriptional interference, or modulation of alternative splicing[2]. OVCH1-AS1 has been found to be differentially expressed in relation to frailty in elderly individuals, suggesting a possible regulatory or biomarker role in age-associated physiological decline[5]. There are currently no described direct small molecule or therapeutic interventions targeting OVCH1-AS1, and no evidence suggesting it functions as a conventional therapeutic target (such as a receptor, enzyme, or transporter). Associations with diseases like hepatocellular carcinoma or glioma in gene databases are not yet functionally substantiated and may reflect its general involvement in cellular regulatory networks as an lncRNA[8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on OVCH1 antisense RNA 1 (OVCH1-AS1).